Cameron Deatsch - 24 Nov 2023 Form 4 Insider Report for Atlassian Corp (TEAM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Nov 2023, 17:13:27 UTC
Prior SEC filing
22 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Veena Bhatia, Attorney-in-Fact for DEATSCH CAMERON

Key filing fact

Cameron Deatsch filed Form 4 for Atlassian Corp (TEAM) on 27 Nov 2023.

Key facts

  • This page summarizes Cameron Deatsch's Form 4 filing for Atlassian Corp (TEAM).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Nov 2023, 17:13.

Change

  • Previous filing in this sequence was filed on 22 Nov 2023.
  • Current net transaction value: -$704,226.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TEAM transaction

Class A Common Stock

Sale

Transaction value
$484,374
Shares
-2,672
Change %
-2.3%
Price
$181.28
Shares after
111,248
Date
24 Nov 2023
Ownership
Direct
Footnotes
F1, F2
TEAM transaction

Class A Common Stock

Sale

Transaction value
$183,495
Shares
-1,018
Change %
-0.92%
Price
$180.25
Shares after
110,230
Date
24 Nov 2023
Ownership
Direct
Footnotes
F1, F3
TEAM transaction

Class A Common Stock

Sale

Transaction value
$36,357
Shares
-200
Change %
-0.18%
Price
$181.78
Shares after
110,030
Date
24 Nov 2023
Ownership
Direct
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023.

Footnote F2

This transaction was executed in multiple trades during the day at prices ranging from $180.64 to $181.61. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Footnote F3

This transaction was executed in multiple trades during the day at prices ranging from $179.62 to $180.55. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Footnote F4

This transaction was executed in multiple trades during the day at prices ranging from $181.74 to $181.83. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .